GLP-1 Physiology and Pharmacology Along the Gut-Brain Axis
Protective effects of bilberry and lingonberry extracts against blue light-emitting diode light-induced retinal photoreceptor cell damage in vitro
Retatrutide works by simultaneously targeting three key hormone receptors: The GIP receptor (glucose-dependent insulinotropic polypeptide) The glucagon-like peptide-1 (GLP-1) receptor The glucagon receptor This triple-agonist activation sets retatrutide apart from traditional weight loss medications, offering the potential for enhanced efficacy and a more comprehensive impact on the underlying mechanisms of obesity
Shortly after starting tirzepatide in October, she noticed what she at first thought were signs of typical injection site irritation: some redness and itching
Key highlights: Once-daily oral administration No food or water restrictions No injections required ~12% mean weight loss in Phase 3 trials Improvements in cardiometabolic risk markers Indication: Approved for adults with obesity, or overweight individuals with weight-related comorbidities, alongside reduced-calorie diet and increased physical activity
Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin